Altimmune, Inc. (ALT) › Net IncomeAltimmune, Inc. (ALT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$34.85M2011: -$3.80M2012: -$4.92M2013: -$11.72M2014: -$9.96M2015: -$3.44M2016: -$11.09M2017: -$46.43M2018: -$39.17M2019: -$20.52M2020: -$49.04M2021: -$97.09M2022: -$84.71M2023: -$88.45M2024: -$95.06M2025: -$88.09M-$88.09M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$88.09M+7.3%2024-$95.06M-7.5%2023-$88.45M-4.4%2022-$84.71M+12.7%2021-$97.09M-98.0%2020-$49.04M-139.0%2019-$20.52M+47.6%2018-$39.17M+15.6%2017-$46.43M-318.7%2016-$11.09M-222.2%2015-$3.44M+65.4%2014-$9.96M+15.0%2013-$11.72M-138.2%2012-$4.92M-29.6%2011-$3.80M+89.1%2010-$34.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share